申请人:C4 Therapeutics, Inc.
公开号:US20210009559A1
公开(公告)日:2021-01-14
The present invention provides cereblon binders for the degradation of Ikaros or Aiolos by the ubiquitin proteasome pathway along with their use in therapeutic applications as described herein.